Toggle navigation
Toggle navigation
Home
DCUM Forums
Nanny Forums
Events
About DCUM
Advertising
Search
Recent Topics
Hottest Topics
FAQs and Guidelines
Privacy Policy
Your current identity is: Anonymous
Login
Preview
Subject:
Forum Index
»
Political Discussion
Reply to "RFKjr Tapped to Head HHS"
Subject:
Emoticons
More smilies
Text Color:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Violet
White
Black
Font:
Very Small
Small
Normal
Big
Giant
Close Marks
[quote=Anonymous]Must all vaccines go through the above process? Yes, all vaccines intended for use in the United States must go through a rigorous FDA process to ensure safety, efficacy, and quality. However, there are some variations depending on the situation: 1. Standard Approval Process • Most vaccines go through the full process, including preclinical research, clinical trials (Phases 1–3), and FDA review. • This applies to vaccines developed for non-urgent public health needs. 2. Emergency Use Authorization (EUA) • In public health emergencies (e.g., pandemics), the FDA may grant an EUA to allow temporary use of a vaccine before full approval. • To receive an EUA, vaccine developers must provide substantial evidence from clinical trials showing that the vaccine is likely effective and that its benefits outweigh potential risks. • Even under an EUA, vaccines must undergo preclinical studies, clinical trials, and FDA review of safety and efficacy data. 3. Accelerated or Priority Review • The FDA can expedite the review process for vaccines addressing critical public health issues (e.g., fast-tracking or priority review). • This doesn’t skip steps but speeds up the timeline by allocating more resources to the review process. 4. Exceptions for Existing Platforms • Vaccines based on well-studied platforms (e.g., those using technologies already approved for other vaccines) may require fewer initial studies, as long as the safety and efficacy of the platform are well-documented. • Even in these cases, clinical trials and a thorough review are still mandatory. 5. Post-Market Requirements • For all vaccines, post-market surveillance is essential, whether the vaccine is fully approved or authorized under an EUA. The FDA requires continued data collection to monitor long-term safety and effectiveness. No vaccine can bypass the core requirements for ensuring safety and efficacy, though the timeline and specific steps may be adjusted in emergencies or for certain situations.[/quote]
Options
Disable HTML in this message
Disable BB Code in this message
Disable smilies in this message
Review message
Search
Recent Topics
Hottest Topics